Literature DB >> 8353182

Purification and partial characterization of relaxin and relaxin precursors from the hamster placenta.

R H Renegar1, C R Owens, J M Chalovich.   

Abstract

Previous immunological studies have indicated that the molecular structure of hamster relaxin is quite different from that of porcine relaxin. In the present study, hamster relaxin was purified from placentas and characterized in order to investigate its biochemical properties. Placentas from Days 14 and 15 of gestation were homogenized in 0.26 N HCl-62.5% acetone containing protease inhibitors. After centrifugation, soluble proteins were acetone precipitated. Soluble proteins were applied to a carboxymethyl cellulose ion-exchange column and bound proteins were eluted with 0.1 and 0.3 M NaCl. Western blot analysis detected 16.5-, 18.7-, and 36.0-kDa relaxin-immunoreactive (IR) proteins within the 0.1 M NaCl eluant and detected a 5.6-kDa relaxin-IR protein within the 0.3 M NaCl eluant. The 5.6-kDa protein was purified to homogeneity by gel filtration (Sephadex G-50), ion-exchange HPLC, and C18-HPLC. Reduction of the 5.6-kDa protein prior to electrophoresis resulted in a single band of lower molecular mass, suggesting that hamster relaxin consists of two chains of approximately equal molecular mass. Isoelectric point of the 5.6-kDa protein was 7.78. The 16.5- and 18.7-kDa IR proteins were copurified by gel filtration and ion-exchange HPLC. At least five isoelectric point variants were observed for the 16.5- and 18.7-kDa proteins. The N-terminal amino acid for the 5.6 and 18.7 relaxin-IR proteins was arginine, and subsequent cycles indicated an identical partial sequence that was consistent with that for relaxins from other species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353182      PMCID: PMC1201550          DOI: 10.1095/biolreprod49.1.154

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  26 in total

1.  Target tissues for relaxin identified in vitro with 125I-labelled porcine relaxin.

Authors:  J P McMurtry; S C Kwok; G D Bryant-Greenwood
Journal:  J Reprod Fertil       Date:  1978-07

2.  Purification and characterization of rat relaxin.

Authors:  O D Sherwood
Journal:  Endocrinology       Date:  1979-04       Impact factor: 4.736

3.  Purification and characterization of porcine relaxin.

Authors:  C D Sherwood; E M O'Byrne
Journal:  Arch Biochem Biophys       Date:  1974-01       Impact factor: 4.013

4.  Evidence for a "pro-relaxin" in porcine relaxin concentrates.

Authors:  E H Frieden; L Yeh
Journal:  Proc Soc Exp Biol Med       Date:  1977-03

5.  High molecular weight forms of relaxin in pregnant sow ovaries.

Authors:  S C Kwok; W A Chamley; G D Bryant-Greenwood
Journal:  Biochem Biophys Res Commun       Date:  1978-06-14       Impact factor: 3.575

6.  Isolation and characterization of relaxin from the sand tiger shark (Odontaspis taurus).

Authors:  J W Reinig; L N Daniel; C Schwabe; L K Gowan; B G Steinetz; E M O'Byrne
Journal:  Endocrinology       Date:  1981-08       Impact factor: 4.736

7.  Radioimmunoassay (RIA) of relaxin in sera of various species using an antiserum to porcine relaxin.

Authors:  E M O'Byrne; B G Steinetz
Journal:  Proc Soc Exp Biol Med       Date:  1976-06

8.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

9.  Purification and immunohistochemical localization of relaxin in the human term placenta.

Authors:  P A Fields; L H Larkin
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

10.  Immunocytochemical localization of relaxin in endometrial glands of the pregnant guinea pig.

Authors:  R Pardo; L H Larkin; P A Fields
Journal:  Endocrinology       Date:  1980-12       Impact factor: 4.736

View more
  1 in total

1.  Production of human pro-relaxin H2 in the yeast Pichia pastoris.

Authors:  D Cimini; K Della Corte; R Finamore; L Andreozzi; A Stellavato; A V A Pirozzi; F Ferrara; R Formisano; M De Rosa; M Chino; L Lista; A Lombardi; V Pavone; C Schiraldi
Journal:  BMC Biotechnol       Date:  2017-01-14       Impact factor: 2.563

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.